Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
South Korea
No access to market insights

The increasing prevalence of target diseases, high awareness, and well-established healthcare structure are some of the key factors driving the market in South Korea. The prevalence of osteoporosis in Korean adults aged 50 or above was 35.5% in women and 7.5% in men.

The estimated osteoporosis diagnosis rate was 26.2% (men 5.8% & women 29.9%) and the treatment rate was 12.8%. Global and local pharmaceutical companies and research organizations are adopting different market strategies to improve women’s health in South Korea.

For instance, in June 2020, Daewon Pharmaceutical launched the teriparatide biosimilar Terrosa used for the treatment of osteoporosis in postmenopausal women. Similarly, in December 2023, Zydus Lifesciences Ltd.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Scope

Women's health market segmentation & scope
Application
Hormonal Infertility
Contraceptives
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Polycystic Ovary Syndrome (PCOS)
Drug Class
Hormonal Therapies
Bone Health Agents
Fertility Agents
GnRH Modulators
Pain and Symptom Management
Metabolic Agents
Others
Age
50 years and above
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Others
Others

Women's Health Market Companies

Name Profile # Employees HQ Website

South Korea women's health market

South Korea Women's Health Market Outlook Share, 2024 & 2030 (US$M)

South Korea women's health market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more